Xenodiagnosis was positive for B. burgdorferi DNA in the person with
erythema migrans who underwent xenodiagnosis early during therapy and in a volunteer with PTLDS.
Participants included 10 people with post-treatment Lyme disease syndrome (PTLDS); 10 who had high levels of an antibody against B. burgdorferi after antibiotic treatment; five who had erythema migrans (a bull's - eye rash) and had received antibiotic treatment in the past; one person with
erythema migrans who began antibiotic therapy at the time of tick placement; and 10 healthy volunteers.
Not exact matches
The guidelines cover three common issues faced by clinicians: management of a known tick bite, antibiotic treatment of patients with
erythema migrans rash, and management of patients
who remain ill following antibiotic therapy for Lyme disease.